Wednesday, September 7, 2011
7:00 a.m. - 9:00 a.m.
Add to Calendar
Tuesday, September 6, 2011 12:00 p.m.
Where Hyatt Regency La Jolla
3777 La Jolla Village Drive
San Diego, California 92122
Corner Office: Meek and timid need not apply. What is it really like being a biotech CEO?
Being CEO sounds glamorous, but is it really? When a biotech advances a project into the clinic, signs a licensing deal or announces an acquisition, there are kudos for all. But when a biotech needs to down size, discontinue a project or simply close the doors, you can be certain that the CEO is feeling the pain and probably accepting the blame. This panel has 6 grizzled veterans of the biotech battles. Each panelist has had successes but not in the absence of rough times. This panel will discuss the good, the bad and the ugly of being a biotech CEO.
Jim Schaeffer, Executive Director, Merck Research Labs
Bob Baltera, CEO, Amira Pharmaceuticals
Rich Heyman, CEO, Aragon Pharmaceuticals
Bert Liang, CEO, Pfenex Inc
Laura Shawver, Former CEO, Phenomix Corp
Jay Short, CEO, BioAtla,LLC
Gonul Velicelebi, CEO, CalciMedica
Planner Ashleigh Berry